Consensus statement on diagnostic criteria for PHACE syndrome

Denise Metry, Geoffrey Heyer, Christopher Hess, Maria Garzon, Anita Haggstrom, Peter Frommelt, Denise Adams, Dawn Siegel, Karla Hall, Julie Powell, Ilona Frieden, Beth Drolet

Research output: Contribution to journalArticle

218 Citations (Scopus)

Abstract

OBJECTIVES: A subgroup of patients with infantile hemangiomas have associated structural anomalies of the brain, cerebral vasculature, eyes, sternum, and/or aorta in the neurocutaneous disorder known as PHACE syndrome. The diagnosis has been broadly inclusive by using a case definition of a facial hemangioma plus ≥1 extracutaneous features, leading to numerous reports of potential associated disease features, many of uncertain significance. This consensus statement was thus developed to establish diagnostic criteria for PHACE syndrome. METHODS: A multidisciplinary group of specialists with expertise in PHACE syndrome drafted initial diagnostic criteria on the basis of review of published, peer-reviewed medical literature and clinical experience. The group then convened in both executive and general sessions during the PHACE Syndrome Research Conference held in November 2008 for discussion and used a consensus method. All conflicting recommendations were subsequently reconciled via electronic communication and teleconferencing. RESULTS: These criteria were stratified into 2 categories: (1) PHACE syndrome or (2) possible PHACE syndrome. Major and minor criteria were determined for the following organ systems: cerebrovascular, structural brain, cardiovascular, ocular, and ventral/midline. Definite PHACE requires the presence of a characteristic segmental hemangioma or hemangioma >5 cm on the face or scalp plus 1 major criterion or 2 minor criteria. Possible PHACE requires the presence of a hemangioma >5 cm on the face or scalp plus 1 minor criterion. The group recognized that it may be possible to have PHACE syndrome with a hemangioma affecting the neck, chest, or arm only or no cutaneous hemangioma at all. In such cases, fulfillment of additional required criteria would also lead to a possible PHACE diagnosis. CONCLUSIONS: These criteria represent current knowledge and are expected to enhance future assessments of PHACE syndrome. It is understood that modifications are to be expected over time to incorporate new research findings.

Original languageEnglish
Pages (from-to)1447-1456
Number of pages10
JournalPediatrics
Volume124
Issue number5
DOIs
StatePublished - Nov 2009

Fingerprint

Hemangioma
Consensus
Scalp
Neurocutaneous Syndromes
Sternum
Peer Review
Brain
Research
Aorta
Arm
Neck
Thorax
Communication
Skin

Keywords

  • Diagnostic criteria
  • Hemangioma
  • PHACE syndrome
  • PHACES syndrome

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Metry, D., Heyer, G., Hess, C., Garzon, M., Haggstrom, A., Frommelt, P., ... Drolet, B. (2009). Consensus statement on diagnostic criteria for PHACE syndrome. Pediatrics, 124(5), 1447-1456. https://doi.org/10.1542/peds.2009-0082

Consensus statement on diagnostic criteria for PHACE syndrome. / Metry, Denise; Heyer, Geoffrey; Hess, Christopher; Garzon, Maria; Haggstrom, Anita; Frommelt, Peter; Adams, Denise; Siegel, Dawn; Hall, Karla; Powell, Julie; Frieden, Ilona; Drolet, Beth.

In: Pediatrics, Vol. 124, No. 5, 11.2009, p. 1447-1456.

Research output: Contribution to journalArticle

Metry, D, Heyer, G, Hess, C, Garzon, M, Haggstrom, A, Frommelt, P, Adams, D, Siegel, D, Hall, K, Powell, J, Frieden, I & Drolet, B 2009, 'Consensus statement on diagnostic criteria for PHACE syndrome', Pediatrics, vol. 124, no. 5, pp. 1447-1456. https://doi.org/10.1542/peds.2009-0082
Metry D, Heyer G, Hess C, Garzon M, Haggstrom A, Frommelt P et al. Consensus statement on diagnostic criteria for PHACE syndrome. Pediatrics. 2009 Nov;124(5):1447-1456. https://doi.org/10.1542/peds.2009-0082
Metry, Denise ; Heyer, Geoffrey ; Hess, Christopher ; Garzon, Maria ; Haggstrom, Anita ; Frommelt, Peter ; Adams, Denise ; Siegel, Dawn ; Hall, Karla ; Powell, Julie ; Frieden, Ilona ; Drolet, Beth. / Consensus statement on diagnostic criteria for PHACE syndrome. In: Pediatrics. 2009 ; Vol. 124, No. 5. pp. 1447-1456.
@article{d83f4162287a44729f4fd9ea9534a9c7,
title = "Consensus statement on diagnostic criteria for PHACE syndrome",
abstract = "OBJECTIVES: A subgroup of patients with infantile hemangiomas have associated structural anomalies of the brain, cerebral vasculature, eyes, sternum, and/or aorta in the neurocutaneous disorder known as PHACE syndrome. The diagnosis has been broadly inclusive by using a case definition of a facial hemangioma plus ≥1 extracutaneous features, leading to numerous reports of potential associated disease features, many of uncertain significance. This consensus statement was thus developed to establish diagnostic criteria for PHACE syndrome. METHODS: A multidisciplinary group of specialists with expertise in PHACE syndrome drafted initial diagnostic criteria on the basis of review of published, peer-reviewed medical literature and clinical experience. The group then convened in both executive and general sessions during the PHACE Syndrome Research Conference held in November 2008 for discussion and used a consensus method. All conflicting recommendations were subsequently reconciled via electronic communication and teleconferencing. RESULTS: These criteria were stratified into 2 categories: (1) PHACE syndrome or (2) possible PHACE syndrome. Major and minor criteria were determined for the following organ systems: cerebrovascular, structural brain, cardiovascular, ocular, and ventral/midline. Definite PHACE requires the presence of a characteristic segmental hemangioma or hemangioma >5 cm on the face or scalp plus 1 major criterion or 2 minor criteria. Possible PHACE requires the presence of a hemangioma >5 cm on the face or scalp plus 1 minor criterion. The group recognized that it may be possible to have PHACE syndrome with a hemangioma affecting the neck, chest, or arm only or no cutaneous hemangioma at all. In such cases, fulfillment of additional required criteria would also lead to a possible PHACE diagnosis. CONCLUSIONS: These criteria represent current knowledge and are expected to enhance future assessments of PHACE syndrome. It is understood that modifications are to be expected over time to incorporate new research findings.",
keywords = "Diagnostic criteria, Hemangioma, PHACE syndrome, PHACES syndrome",
author = "Denise Metry and Geoffrey Heyer and Christopher Hess and Maria Garzon and Anita Haggstrom and Peter Frommelt and Denise Adams and Dawn Siegel and Karla Hall and Julie Powell and Ilona Frieden and Beth Drolet",
year = "2009",
month = "11",
doi = "10.1542/peds.2009-0082",
language = "English",
volume = "124",
pages = "1447--1456",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "5",

}

TY - JOUR

T1 - Consensus statement on diagnostic criteria for PHACE syndrome

AU - Metry, Denise

AU - Heyer, Geoffrey

AU - Hess, Christopher

AU - Garzon, Maria

AU - Haggstrom, Anita

AU - Frommelt, Peter

AU - Adams, Denise

AU - Siegel, Dawn

AU - Hall, Karla

AU - Powell, Julie

AU - Frieden, Ilona

AU - Drolet, Beth

PY - 2009/11

Y1 - 2009/11

N2 - OBJECTIVES: A subgroup of patients with infantile hemangiomas have associated structural anomalies of the brain, cerebral vasculature, eyes, sternum, and/or aorta in the neurocutaneous disorder known as PHACE syndrome. The diagnosis has been broadly inclusive by using a case definition of a facial hemangioma plus ≥1 extracutaneous features, leading to numerous reports of potential associated disease features, many of uncertain significance. This consensus statement was thus developed to establish diagnostic criteria for PHACE syndrome. METHODS: A multidisciplinary group of specialists with expertise in PHACE syndrome drafted initial diagnostic criteria on the basis of review of published, peer-reviewed medical literature and clinical experience. The group then convened in both executive and general sessions during the PHACE Syndrome Research Conference held in November 2008 for discussion and used a consensus method. All conflicting recommendations were subsequently reconciled via electronic communication and teleconferencing. RESULTS: These criteria were stratified into 2 categories: (1) PHACE syndrome or (2) possible PHACE syndrome. Major and minor criteria were determined for the following organ systems: cerebrovascular, structural brain, cardiovascular, ocular, and ventral/midline. Definite PHACE requires the presence of a characteristic segmental hemangioma or hemangioma >5 cm on the face or scalp plus 1 major criterion or 2 minor criteria. Possible PHACE requires the presence of a hemangioma >5 cm on the face or scalp plus 1 minor criterion. The group recognized that it may be possible to have PHACE syndrome with a hemangioma affecting the neck, chest, or arm only or no cutaneous hemangioma at all. In such cases, fulfillment of additional required criteria would also lead to a possible PHACE diagnosis. CONCLUSIONS: These criteria represent current knowledge and are expected to enhance future assessments of PHACE syndrome. It is understood that modifications are to be expected over time to incorporate new research findings.

AB - OBJECTIVES: A subgroup of patients with infantile hemangiomas have associated structural anomalies of the brain, cerebral vasculature, eyes, sternum, and/or aorta in the neurocutaneous disorder known as PHACE syndrome. The diagnosis has been broadly inclusive by using a case definition of a facial hemangioma plus ≥1 extracutaneous features, leading to numerous reports of potential associated disease features, many of uncertain significance. This consensus statement was thus developed to establish diagnostic criteria for PHACE syndrome. METHODS: A multidisciplinary group of specialists with expertise in PHACE syndrome drafted initial diagnostic criteria on the basis of review of published, peer-reviewed medical literature and clinical experience. The group then convened in both executive and general sessions during the PHACE Syndrome Research Conference held in November 2008 for discussion and used a consensus method. All conflicting recommendations were subsequently reconciled via electronic communication and teleconferencing. RESULTS: These criteria were stratified into 2 categories: (1) PHACE syndrome or (2) possible PHACE syndrome. Major and minor criteria were determined for the following organ systems: cerebrovascular, structural brain, cardiovascular, ocular, and ventral/midline. Definite PHACE requires the presence of a characteristic segmental hemangioma or hemangioma >5 cm on the face or scalp plus 1 major criterion or 2 minor criteria. Possible PHACE requires the presence of a hemangioma >5 cm on the face or scalp plus 1 minor criterion. The group recognized that it may be possible to have PHACE syndrome with a hemangioma affecting the neck, chest, or arm only or no cutaneous hemangioma at all. In such cases, fulfillment of additional required criteria would also lead to a possible PHACE diagnosis. CONCLUSIONS: These criteria represent current knowledge and are expected to enhance future assessments of PHACE syndrome. It is understood that modifications are to be expected over time to incorporate new research findings.

KW - Diagnostic criteria

KW - Hemangioma

KW - PHACE syndrome

KW - PHACES syndrome

UR - http://www.scopus.com/inward/record.url?scp=70350497705&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70350497705&partnerID=8YFLogxK

U2 - 10.1542/peds.2009-0082

DO - 10.1542/peds.2009-0082

M3 - Article

VL - 124

SP - 1447

EP - 1456

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 5

ER -